Cell therapy is rapidly expanding, with a growing number of innovative programs emerging across both academic institutions and industry. The development of successful cell therapy products is inherently complex, requiring close integration of multidisciplinary expertise toward a shared goal. Our program has demonstrated sustained leadership in the field through the development of pioneering therapies, including virus-specific CTLs and a groundbreaking CAR NK platform. Today, we are recognized as global leaders in the clinical development and application of CAR-NK therapies for cancer treatment.
The research intern will gain hands-on experience in analyzing experimental data related to NK cell function, including cytotoxicity assays such as real-time imaging platforms and (Cr51) release assays. The intern will be exposed to a broad range of immunotherapy research techniques and will develop foundational knowledge in flow cytometry, specimen processing, and data interpretation. In add...